Source:http://linkedlifedata.com/resource/pubmed/id/10497846
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-10-26
|
pubmed:abstractText |
In this study, we examined the role of Fas-signaling in the apoptotic pathway in myelodysplastic syndromes (MDS). Ficoll-separated mononuclear cells from 18 bone marrow aspirate specimens obtained from 17 MDS patients, 4 normal healthy donors, and 3 acute myeloid leukemia patients transformed from MDS (t-AML) were studied for mRNA expression of Fas-L, Fas, and the effectors of their signaling, Caspase 1 and Caspase 3, using reverse transcriptase polymerase chain reaction. Fas-L, Fas, and Caspase 1 were detectable in all of the samples in the three groups. Caspase 3 was detectable both in MDS and t-AML specimens but was negligible in normal cells. The apoptotic index (AI%) determined by in situ end labeling of fragmented DNA in 4-hour cultures of mononuclear cells was significantly higher in MDS cells compared to normal or t-AML cells (mean +/- SEM: 2.3% +/- 0.4% in MDS, n = 10 vs. 0.6% +/- 0.2%, n = 4, P = 0.014 in normal cells, and 0.2% +/- 0.2%, n = 3, P = 0.007 in t-AML cells). Treatment of MDS cells with anti-Fas-L antibody suppressed apoptosis (AI%: 2.1% +/- 0.6% in untreated vs. 1.37% +/- 0.5% in treated, n = 6, P = 0.02), indicating functional participation of Fas-signaling in MDS. Further, it was found that Fas-L, Fas, and Caspase 1 mRNA expression remained unchanged in 4 hours. Caspase 3 expression appeared in normal cells after 4 hours and was present at both 0 and 4 hours in MDS and t-AML cells. In contrast to persistent expression in normal and t-AML cells, cells from the 5 MDS patients studied consistently showed significantly lowered or undetectable expression of a negative regulator of Fas, called Fas-associated phosphatase-1 (Fap-1) after 4 hours. Thus, the high AI% in MDS corresponds to a rapid decline in Fap-1. Furthermore, in tumor necrosis factor alpha (TNF-alpha) treated HL60 promyelocytic cells, a definite periodicity in the expression of different mRNAs was observed with upregulation of TNF-alpha itself at 30 minutes, increased expression of Fas and the appearance of Fas-L after 2 hours, and a decrease in Fap-1 expression after 8 hours. These results suggest that TNF-alpha not only induces the effectors of Fas-signaling but also may downregulate the inhibitor. We conclude that a spontaneous and rapid down-regulation of Fap-1, possibly induced by TNF-alpha, a cytokine shown to be present in excess in MDS marrows, may underlie the increased apoptotic death of hematopoietic cells in these patients. Interference with Fap-1 turnover may provide a new therapeutic modality for MDS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95,
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/PTPN13 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Phosphatase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Tyrosine Phosphatase...,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Tyrosine Phosphatases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0925-5710
|
pubmed:author |
pubmed-author:BagarBB,
pubmed-author:CartlidgeJ DJD,
pubmed-author:CheemaPP,
pubmed-author:FeldmanGG,
pubmed-author:GautamUU,
pubmed-author:GregoryS ASA,
pubmed-author:MativiB YBY,
pubmed-author:MungerM AMA,
pubmed-author:RazaAA,
pubmed-author:ReynAA,
pubmed-author:RifkinSS,
pubmed-author:RobinEE,
pubmed-author:ShahRR,
pubmed-author:ShettyVV,
pubmed-author:VenugopalPP
|
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
83-90
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10497846-Antigens, CD95,
pubmed-meshheading:10497846-Apoptosis,
pubmed-meshheading:10497846-Bone Marrow,
pubmed-meshheading:10497846-Carrier Proteins,
pubmed-meshheading:10497846-Down-Regulation,
pubmed-meshheading:10497846-Enzyme Activation,
pubmed-meshheading:10497846-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:10497846-Humans,
pubmed-meshheading:10497846-Myelodysplastic Syndromes,
pubmed-meshheading:10497846-Protein Phosphatase 1,
pubmed-meshheading:10497846-Protein Tyrosine Phosphatase, Non-Receptor Type 13,
pubmed-meshheading:10497846-Protein Tyrosine Phosphatases
|
pubmed:year |
1999
|
pubmed:articleTitle |
Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
|
pubmed:affiliation |
Rush Cancer Institute, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA. smundle@rush.edu
|
pubmed:publicationType |
Journal Article
|